OTC : DNAG

DNAPrint Genomics, Inc.

$2e-05 USD

$0 (0.0%)

Volume
331.5K
Average Volume
323.08K
Market Capitalization
$12.89K
P/E Ratio
0.00
Dividend Yield
0.00%
Price Target
Year High
$0.00
Year Low
$0.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.64
Company Overview

OTC

Jatin Patel

Biotechnology

Healthcare

DNAG

24

US

USD

N/A

23324Q202

N/A

Liquidity Metrics

-1.96

0.64

0.63

0.04

0.00

Sales & Valuation

$2.43M

0.01

0.00

0.00

-0.02

Profitability

-$0.03

-$12.35M

-507.54%

0.00%

316.59%

-120.24%

P/E Metrics

0.00

0.00

0.00

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

-30.04

3/9

-$9.35M

$3.11M

$11.5M

-$5.91M

Key Metrics (TTM)

$6.7M

2.75

-0.75

0.64

316.59%

0.00%

-169045.16%

-47884.22%

-622 days

Company Executives
Name Title
Hector de Jesus Ruiz Executive Officer
Laurence A. Rubin Executive Officer
Naz Jiwani Executive Officer
Lisa Tandy Herren Executive Officer
Pauline Gula Executive Officer
Zach Gaskin Executive Officer
Jatin Patel Executive Officer
Emanuela Charlton Executive Officer
Scot Alic Executive Officer
Shannon Boyd Executive Officer
Poll Results

No votes yet today — be the first to share your view!

About DNAPrint Genomics, Inc. (OTC:DNAG) Stock

DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis solutions and services. Their product portfolio includes AncestryByDNA, a comprehensive chromosomal assay for tracing genetic lineage, and EurasianDNA, designed to identify specific European ancestral subdivisions. They also offer EuropeanDNA, which outlines an individual's fundamental continental European heritage. In forensic science, DNAWitness assists in determining genetic background from crime scene samples, while RETINOME is utilized by detectives to construct physical traits, such as eye color, from DNA evidence or human remains. Furthermore, the company provides the GenomeLab SNPstream Genotyping System, recognized for its high genotyping throughput, multiplexing capabilities, and efficient reagent usa ... ge. DNAPrint Genomics caters to diverse clients in fields like forensic investigation, genealogical exploration, consumer products, and pharmaceutical research. Originally incorporated in 1983 as Lexington Energy, Inc., the company operates from Sarasota, Florida, with an international presence through a subsidiary in Leverkusen, Germany.

Frequently Asked Questions

What is the current DNAPrint Genomics, Inc. (DNAG) stock price?

DNAPrint Genomics, Inc.(OTC:DNAG) stock price is $2e-05 in the last trading session. During the trading session, DNAG stock reached the peak price of $0.00002 while $0.000001 was the lowest point it dropped to. The percentage change in DNAG stock occurred in the recent session was 0.0% while the dollar amount for the price change in DNAG stock was $0.

DNAG's industry and sector of operation?

The OTC listed DNAG is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of DNAG?

Hector de Jesus Ruiz | Executive Officer
Laurence A. Rubin | Executive Officer
Naz Jiwani | Executive Officer
Lisa Tandy Herren | Executive Officer
Pauline Gula | Executive Officer

How many employees does DNAG have?

Number of DNAG employees currently stands at 24. DNAG operates from 1621 West University Parkway, Sarasota, FL 34243, US.

Link for DNAG official website?

Official Website of DNAG is: http://www.dnaprint.com

How do I contact DNAG?

DNAG could be contacted at phone #None and can also be accessed through its website. DNAG operates from 1621 West University Parkway, Sarasota, FL 34243, US.

How many shares of DNAG are traded daily?

The average number of DNAG shares traded daily for last 3 months was 323.08K.

What is the market cap of DNAG currently?

The market value of DNAG currently stands at $12.89K with its latest stock price at $2e-05